insights_auto
Kwa nini AGIO imepungua kwa 3.10%?
Fahamu zaidichevron_right
AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ 28.76
arrow_downward
-3.10%(-0.92) Siku 1
US$ 28.76
0.00% (0.00)
bedtimeBaada ya saa
Imefungwa: 19 Nov, 16:00:01 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AGIO...
Fungua
US$ 29.93
Juu
US$ 30.35
Chini
US$ 28.71
Mtaji wa soko
1.72B
Wastani wa kiasi cha mauzo
1.18M
Kiasi cha mauzo ya hisa
elfu 467.78
Juu kwa wiki 52
US$ 44.07
Chini kwa wiki 52
US$ 23.02
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Fungua
US$ 29.93
Juu
US$ 30.35
Chini
US$ 28.71
Mtaji wa soko
1.72B
Wastani wa kiasi cha mauzo
1.18M
Kiasi cha mauzo ya hisa
elfu 467.78
Juu kwa wiki 52
US$ 44.07
Chini kwa wiki 52
US$ 23.02
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
ChartMill
·
saa 1 iliyopita
S&P 500 Top Movers: Gainers and Losers Today
MarketWatch
·
dakika 34 zilizopita
Dow, S&P 500, Nasdaq end sharply lower after Anthropic’s public-market debut
24/7 Wall St.
·
dakika 5 zilizopita
S&P 500 Drops Nearly 2% at the Close as Rate Hike Talk Hits Markets
Traders Union
·
saa 1 iliyopita
Caleb Franzen: S&P 500 performance and AI stocks diverged under Powell and Warsh
Wasifu
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Kuhusu Agios Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi540
Lilianzishwa2008
Makao makuu-
SektaHealth Care
Sekta-
Tovutiagios.com